Canadian Province Expands Biosimilar Switching, But Patient Group Voices Concerns

 
• By Aidan Fry
  
Cockpit
Patients with Crohn's disease and ulcerative colitis are to be switched to biosimilars in Canada's British Columbia province • Source: Shutterstock

More from Biosimilars

More from Products